Prof. Dr. John Ellershaw - Dehydration and the dying Patient

More documents

Recommendations

Info

USE OF HYPODERMOCLYSIS FOR REHYDRATION IN TERMINALLY ILL CANCER PATIENTS (Fainsinger 1994) 100 consecutive patients 69 received HDC - average 14 days 1200mls subcutaneously per day Hyaluronidase 750 units/litre
SITE CHANGES OF SUBCUTANEOUS NEEDLE 71 cases - Leakage/Swelling 56 cases - Inflammation 16 cases - Bleeding/ Bruising NO ASSESSMENT OF SYMPTOM CONTROL
Page 1 and 2: DEHYDRATION AND THE DYING PATIENT J
Page 3 and 4: Clinical Scenario
Page 6 and 7: DEHYDRATION Symptoms relieved by lo
Page 8 and 9: INCLUSION CRITERIA > 18 yrs diagnos
Page 10 and 11: CONCLUSION Symptoms: Increased fati
Page 13 and 14: HYDRATION Decreases distress of pat
Page 15: “It has become our standard of ca
Page 19 and 20: CONCLUSION Standards of care 16% co
Page 21 and 22: The Dying Patient and Dehydration (
Page 23 and 24: CRITERIA FOR INCLUSION Patients adm
Page 25 and 26: BIOCHEMICAL ANALYSIS (N = 82) Mean
Page 27 and 28: Do You Have a Dry Mouth ? 100 80 %
Page 29 and 30: Use Of Drugs Known to Cause Dry Mou
Page 31 and 32: Health Care Professionals Perceptio
Page 33 and 34: DEHYDRATION AND THE DYING PATIENT C
Page 35 and 36: A blanket policy of artificial hydr
Page 37 and 38: Thirst or dry mouth in people who a
Page 39 and 40: It is a responsibility of the clini
Page 41 and 42: Clinical Decision Scenarios Patient
Page 43: Case History 2 Patient is dying and

Prof. Dr. John Ellershaw - Dehydration and the dying Patient

Create successful ePaper yourself

Delete template?

Save as template?